Morris Retirement Advisors »

Halozyme Therapeutics shares owned by Morris Retirement Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Morris Retirement Advisors from 13F filings

Historical chart of Morris Retirement Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Morris Retirement Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Morris Retirement Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $632k 8.6k 73.34
2025-06-30 $454k 8.7k 52.02

More positions owned by Morris Retirement Advisors

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Invesco Exchange Traded Fd T Dj Indl Avg Dv (DJD)
Direxion Shs Etf Tr Nas100 Eql Wgt (QQQE)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Pimco Etf Tr Active Bd Etf (BOND)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Ishares Tr Us Aer Def Etf (ITA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
First Tr Exchange Traded Rba Indl Etf (AIRR)
Apple (AAPL)
Meta Platforms Cl A (META)

View all positions for Morris Retirement Advisors

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics